# LENZ Therapeutics, Inc. (LENZ) MD&A by fiscal year

Verbatim Item 7 Management's Discussion and Analysis sections from LENZ Therapeutics, Inc.'s 10-K filings, one page per fiscal year. Extracted from SEC filings with the same bounded parser for every year. Filer text, not grepcent analysis or investment advice.

- [FY 2025 MD&A](/company/LENZ/mda/fy2025/): filed 2026-03-24; accession 0001815776-26-000011 (https://www.sec.gov/Archives/edgar/data/1815776/000181577626000011/lenz-20251231.htm); latest 10-K
- [FY 2024 MD&A](/company/LENZ/mda/fy2024/): filed 2025-03-19; accession 0001815776-25-000019 (https://www.sec.gov/Archives/edgar/data/1815776/000181577625000019/lenz-20241231.htm)
- [FY 2023 MD&A](/company/LENZ/mda/fy2023/): filed 2024-02-27; accession 0000950170-24-021135 (https://www.sec.gov/Archives/edgar/data/1815776/000095017024021135/grph-20231231.htm)
- [FY 2022 MD&A](/company/LENZ/mda/fy2022/): filed 2023-03-20; accession 0000950170-23-008764 (https://www.sec.gov/Archives/edgar/data/1815776/000095017023008764/grph-20221231.htm)
- [FY 2021 MD&A](/company/LENZ/mda/fy2021/): filed 2022-03-21; accession 0001564590-22-011123 (https://www.sec.gov/Archives/edgar/data/1815776/000156459022011123/grph-10k_20211231.htm)

Back to /company/LENZ/